| | | | | | | | | | |
|
|
| Dockets Entered
On May 25, 2005
Table of Contents
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
| 1997N-0484T
|
| Human Cells, Tissues, and Cellular and Tissue-Based Products; Donor Screening and Testing, and Related Labeling
|
|
|
| 2003D-0263
|
| Draft Guidance for Industry: Channels of Trade Policy for Commodities With Residues of Pesticide Chemicals, for Which Tolerances Have Been Revoked, Suspended, or Modified by the Environmental Protecti
|
|
|
|
| 2005D-0183
|
| Guidance for Industry on Antiviral Drug Development Conducting Virology Studies and Submitting the Data to the Agency
|
|
|
| 2005N-0184
|
| Precursor Preference in Surfactant Synthesis of Newborns
|
|
|
| 2005P-0207
|
| Change in Classification for Sonomet Body Compition Analyzer, BOD POD and PEAPOD
|
|
|
| 2005V-0206
|
| Laser Light Show
|
|
|
| 1997N-0484T
|
| Human Cells, Tissues, and Cellular and Tissue-Based Products; Donor Screening and Testing, and Related Labeling
|
|
|
| NIR
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2003D-0263
|
| Draft Guidance for Industry: Channels of Trade Policy for Commodities With Residues of Pesticide Chemicals, for Which Tolerances Have Been Revoked, Suspended, or Modified by the Environmental Protecti
|
|
|
|
|
|
| NAL
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2005D-0183
|
| Guidance for Industry on Antiviral Drug Development Conducting Virology Studies and Submitting the Data to the Agency
|
|
|
| GDL
1
|
| Guidance
|
| Vol #:
|
| 1
|
|
|
| NAD
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2005N-0184
|
| Precursor Preference in Surfactant Synthesis of Newborns
|
|
|
| N
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| NM
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2005P-0207
|
| Change in Classification for Sonomet Body Compition Analyzer, BOD POD and PEAPOD
|
|
|
| ACK
1
|
| HFA-305 to Life Measurement, Inc
|
| Vol #:
|
| 2
|
|
|
| CCP
1
|
| Life Measurement, Inc
|
| Vol #:
|
| 1
|
|
|
| 2005V-0206
|
| Laser Light Show
|
|
|
| ACK
1
|
| HFA-305 to Glock, Inc.
|
| Vol #:
|
| 1
|
|